His­toric drug pric­ing re­forms pass; Pfiz­er ac­quires GBT; The long search for non-opi­oid pain drugs; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

The End­points Week­ly has of­fi­cial­ly crossed the 60,000 mark on sub­scribers — thanks to all of your sup­port. As the ed­i­to­r­i­al team grows, we’ve been able to do a lot more, with many of those on dis­play this week. Be sure to check out Lei Lei Wu’s deep dive on pain R&D. If you missed it, you may al­so re­watch her com­pan­ion pan­el here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.